Faculty Opinions recommendation of Use of radiation therapy in the last 30 days of life among a large population-based cohort of elderly patients in the United States.

2013 ◽  
Author(s):  
Noelle LoConte ◽  
Ticiana Leal
Keyword(s):  
United States ◽  
Radiation Therapy ◽  
Elderly Patients ◽  
Large Population ◽  
The United States ◽  
Population Based

scholarly journals Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases

Blood ◽  
2009 ◽  
Vol 113 (21) ◽  
pp. 5064-5073 ◽  
Author(s):  
Porcia T. Bradford ◽  
Susan S. Devesa ◽  
William F. Anderson ◽  
Jorge R. Toro
Keyword(s):  
United States ◽  
Large Population ◽  
Survival Rates ◽  
The United States ◽  
Population Based ◽  
Incidence Rates ◽  
T Cell Lymphomas ◽  
Cutaneous Lymphomas ◽  
Distinct Disease ◽  
Asian Pacific

Abstract There have been no prior large population-based studies focusing on cutaneous lymphomas (CL) in the United States. Using the Surveillance, Epidemiology and End Results (SEER) program data, we analyzed age-adjusted CL incidence rates (IRs) and survival rates by sex and race/ethnicity. There were 3884 CLs diagnosed during 2001-2005. Cutaneous T-cell lymphomas (CTCLs) accounted for 71% (age-adjusted incidence rate [IR] = 7.7/1 000 000 person-years), whereas cutaneous B-cell lymphomas(CBCLs) accounted for 29% (IR = 3.1/1 000 000 person-years). Males had a statistically significant higher IR of CL than females (14.0 vs 8.2/1 000 000 person-years, respectively; male-female IR ratio [M/F IRR] = 1.72; P < .001). CL IRs were highest among blacks and non-Hispanic whites (both 11.5/1 000 000 person-years), followed by Hispanic whites (7.9) and Asian/Pacific Islanders (7.1). The CTCL IR was highest among blacks (10.0/1 000 000 person-years), whereas the CBCL IR was highest among non-Hispanic whites (3.5). Over the past 25 years, the CL IR increased from 5.0/1 000 000 person-years during 1980-1982 to 14.3 during 2001-2003. During 2004-2005, the CL IR was 12.7. This recent apparent change could be incomplete case ascertainment or potential leveling off of IRs. CLs rates vary markedly by race and sex, supporting the notion that they represent distinct disease entities.

scholarly journals The Cerebral Palsy Research Registry

2011 ◽  
Vol 26 (12) ◽  
pp. 1534-1541 ◽  
Author(s):  
Donna S. Hurley ◽  
Theresa Sukal-Moulton ◽  
Michael E. Msall ◽  
Deborah Gaebler-Spira ◽  
Kristin J. Krosschell ◽  
...  
Keyword(s):  
United States ◽  
Cerebral Palsy ◽  
Life Span ◽  
Social Systems ◽  
Large Population ◽  
The United States ◽  
Population Based ◽  
Current Status ◽  
Motor Disability ◽  
Prospective Longitudinal

Cerebral palsy is the most common neurodevelopmental motor disability in children. The condition requires medical, educational, social, and rehabilitative resources throughout the life span. Several countries have developed population-based registries that serve the purpose of prospective longitudinal collection of etiologic, demographic, and functional severity. The United States has not created a comprehensive program to develop such a registry. Barriers have been large population size, poor interinstitution collaboration, and decentralized medical and social systems. The Cerebral Palsy Research Registry was created to fill the gap between population and clinical-based cerebral palsy registries and promote research in the field. This is accomplished by connecting persons with cerebral palsy, as well as their families, to a network of regional researchers. This article describes the development of an expandable cerebral palsy research registry, its current status, and the potential it has to affect families and persons with cerebral palsy in the United States and abroad.

scholarly journals Characterization of mitochondrial haplogroups in a large population-based sample from the United States

2014 ◽  
Vol 133 (7) ◽  
pp. 861-868 ◽  
Author(s):  
Sabrina L. Mitchell ◽  
Robert Goodloe ◽  
Kristin Brown-Gentry ◽  
Sarah A. Pendergrass ◽  
Deborah G. Murdock ◽  
...  
Keyword(s):  
United States ◽  
Large Population ◽  
The United States ◽  
Population Based ◽  
Mitochondrial Haplogroups

scholarly journals Use of Radiation Therapy in the Last 30 Days of Life Among a Large Population-Based Cohort of Elderly Patients in the United States

2013 ◽  
Vol 31 (1) ◽  
pp. 80-87 ◽  
Author(s):  
B. Ashleigh Guadagnolo ◽  
Kai-Ping Liao ◽  
Linda Elting ◽  
Sharon Giordano ◽  
Thomas A. Buchholz ◽  
...  
Keyword(s):  
Decision Making ◽  
Radiation Therapy ◽  
Claims Data ◽  
Hospice Care ◽  
Large Population ◽  
The United States ◽  
Population Based ◽  
Physician Decision Making ◽  
End Stage ◽  
Hispanic White

Purpose: Our goal was to evaluate use and associated costs of radiation therapy (RT) in the last month of life among those dying of cancer. Methods: We used the Surveillance, Epidemiology, and End Results (SEER) -Medicare linked databases to analyze claims data for 202,299 patients dying as a result of lung, breast, prostate, colorectal, and pancreas cancers from 2000 to 2007. Logistic regression modeling was used to conduct adjusted analyses of potential impacts of demographic, health services, and treatment-related variables on receipt of RT and treatment with greater than 10 days of RT. Costs were calculated in 2009 dollars. Results: Among the 15,287 patients (7.6%) who received RT in the last month of life, its use was associated with nonclinical factors such as race, gender, income, and hospice care. Of these patients, 2,721 (17.8%) received more than 10 days of treatment. Nonclinical factors that were associated with greater likelihood of receiving more than 10 days of RT in the last 30 days of life included: non-Hispanic white race, no receipt of hospice care, and treatment in a freestanding, versus a hospital-associated facility. Hospice care was associated with 32% decrease in total costs of care in the last month of life among those receiving RT. Conclusion: Although utilization of RT overall was low, almost one in five of patients who received RT in their final 30 days of life spent more than 10 of those days receiving treatment. More research is needed into physician decision making regarding use of RT for patients with end-stage cancer.

Sign in / Sign up

Export Citation Format

Share Document